Latest Morpholines Stories
GENEVA, April 17, 2015 /PRNewswire/ -- ASSESS shows plasma circulating tumour DNA (ctDNA) testing for EGFR mutation is a viable alternative
Application Designed to Support Conversion of Accelerated to Full FDA Approval THOUSAND OAKS, Calif., March 30, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U.S.
The San Diego based law firm with its national network of experienced lawyers comments on the FDA's Adverse Reaction changes to the anticoagulant's labeling, as well as the development
THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Feb.
-- Phase 1 Studies Confirm Superior Safety Profile of MRX-I Over Zyvox® -- HAYWARD, Calif. and SHANGHAI, Feb.
Xarelto Bleeding Lawsuits Filed In Federal And State Courts Allege The Prescription Blood Thinner Causes Uncontrollable Or Fatal Bleeding Due To The Lack Of An Antidote Columbus,
US Submission Designed to Support Conversion From Accelerated to Full FDA Approval and Expansion of Current Approved Indication THOUSAND OAKS, Calif.
The study comes as dozens of plaintiffs, including a number being represented by the Firm, pursue Xarelto lawsuits after allegedly suffering uncontrollable bleeding and other complications due
ReportsnReports.com adds “Global and Chinese Racemoramide Industry, 2009-2019 Market Research Report” to its store. Dallas, TX (PRWEB) January 17, 2015
Findings Add to Rigorous Post-Marketing Safety Program for XARELTO® in Routine Clinical Practice RARITAN, N.J., Jan.
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.